Zbigniew Putowski retweeted
This is getting more crazy jajaja Join us! Just free association academics friends!! Andromeda-shock! Andromeda-shock-2! Andromeda-pegasus! Andromeda-vexus! Andromeda-Nautilus! Andromeda-Horizons! Andromeda-Dragon! Andromeda-Krator! Andromeda-Orion, and more to come
Zbigniew Putowski retweeted
Great ANDROMEDA Research Network in ESICM Lisbon! Investigators from
20 countries discussing future plans! Argentina, Chile, Brazil, Colombia, USA, Japan, Korea, China, Spain, Portugal, France, Belgium, Germany, Sweden, Hungary, Poland, Austria, India, Turkije, Kuwait😍😍💪
Zbigniew Putowski retweeted
What truly defines refractory septic shock? Our new manuscript explores moving beyond vasopressor thresholds to the integration of persistent tissue hypoperfusion.
Read our latest work on @yourICM :
rdcu.be/fuEtx
ICU Stories - Atrial fibrillation:
A few days ago, when I came on service, I took care of a 70 yo patient who had been in the ICU for ~15 days. He had been admitted with an intra-abdominal abscess secondary to colonic perforation. He had undergone colectomy and required twice percutaneous drainage of abscesses. His course was complicated by acute kidney injury requiring continuous renal replacement therapy and hypoxemic respiratory failure requiring high-flow nasal cannula and NIV
During his ICU stay, he had developed new-onset atrial fibrillation with rapid ventricular response (heart rates persistently in the 130-150 bpm range). He was largely asymptomatic aside from occasional palpitations but remained on vasopressor support with norepinephrine (0.05-0.15 mcg/kg/min) and vasopressin 0.04 u/min
For more than 5 days, Cardiology, Electrophysiology, and the ICU team had attempted multiple rate-control strategies, including low-dose beta-blockade, amiodarone boluses and infusion, digoxin, and diltiazem boluses and infusion. None achieved adequate rate control, let alone conversion to sinus rhythm. The prevailing concern was that, because the patient remained septic (he had leukocytosis and some worrisome abdominal fluid collections), cardioversion would be unlikely to succeed
Reversible triggers had been addressed: his oxygenation was adequate, his pain was controlled, and his electrolytes were within acceptable limits. However, the persistent tachy-arrhythmia created a practical problem. Each time fluid removal was attempted through CRRT, the heart rate made both the ICU and Nephrology teams very hesitant to proceed. As a result, patient kept accumulating a positive fluid balance day after day, reaching approximately 15 liters positive by the time I first evaluated him
After reviewing his course and reassessing his physiology, I decided that cardioversion was worth attempting. To the surprise (?) of the Cardiology and Electrophysiology teams, synchronized cardioversion with 100 joules restored sinus rhythm. He has remained in sinus rhythm for the past week. The change was clinically meaningful. We were able to discontinue both vasopressors and achieve negative fluid balance each day thereafter
This is, of course, a single case (a N-of-1 study) rather than definitive evidence. But it reinforced an important lesson for me: in Critical Care, “sepsis-related” AF does not always mean “do nothing.” If the rhythm is contributing to shock, organ dysfunction, or blocking essential therapy, a carefully considered rhythm-control attempt may reveal a missed opportunity to help
#foamed #foamcc
Circulation. 2023;147:e676-e698
DOI: 10.1161/CIR.0000000000001133
Zbigniew Putowski retweeted
We cannot treat a profoundly heterogeneous condition with rigid algorithms. Our latest perspective in Critical Care analyzes 25 years of shock trials, showing why isolated targets fail and how rapid microcirculatory signals pave the way for personalized resuscitation.
Zbigniew Putowski retweeted
My new paper in Critical Care on the microcirculation.
@icmteaching @khaycock2
link.springer.com/article/10…
Zbigniew Putowski retweeted
Today's Paper of the Day is:
Tissue perfusion as the ultimate target of hemodynamic interventions in the perioperative period
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2025
Link in bio
Zbigniew Putowski retweeted
Oddział intensywnej terapii na którym pracuję ma 11 stanowisk. Średnio 6-7 jest zajętych przez pacjentów nadużywających alkoholu (urazy, niewydolność wątroby, krwawienia). Sprzedaż alkoholu gdziekolwiek nie jest tematem zastępczym. W ochronie zdrowia, ale nie tylko olbrzymie środki są tracone na skutki nadużywania alkoholu.
Zbigniew Putowski retweeted
ANDROMEDA- PEGASUS has already recruited app 1700 pts in 180 centers in 4 continents. Unraveling from an epidemiological perspective the RR between pulse pressure and stroke volume in different contexts. Does a normal PP rule-out a low SV: confounders, static and dynamic views💪
Zbigniew Putowski retweeted
Presented at #LIVES2025:
In the EVERDAC trial involving patients with shock, results for death at day 28 indicated that management without early arterial catheter insertion was noninferior to early catheter insertion. Full trial results: nej.md/3LmOO0D
Editorial: A Less Invasive Approach to Intensive Care nej.md/49b1th5
Zbigniew Putowski retweeted
The ANDROMEDA-SHOCK-2 is finally released!! We found that a personalized resuscitation targeting capillary refill time through simple bedside hemodynamic tools was superior to usual care for the composite of mortality/vital support/hospital stay and for faster decrease in SOFA.
Zbigniew Putowski retweeted
Among patients with early #SepticShock, a personalized hemodynamic resuscitation protocol targeting capillary refill time was superior to usual care for the primary composite outcome, primarily driven by a lower duration of vital support.
#LIVES2025 @ESICM
ja.ma/4hv22Vc
Zbigniew Putowski retweeted
Finally out!
4 years of hard work, building friendship, trust and creating an aweosome community with the ANDROMEDA family!!! Thanks @ESICM and @JAMA_current!!!
Among patients with early #SepticShock, a personalized hemodynamic resuscitation protocol targeting capillary refill time was superior to usual care for the primary composite outcome, primarily driven by a lower duration of vital support.
#LIVES2025 @ESICM
ja.ma/4hv22Vc
Zbigniew Putowski retweeted
Today I had the privilege to present results of PREVENT-MINS trial at the #ESCCongress2025 @escardio in Barcelona (Hot-Line session) on behalf of trial investigators.
The study was published simultaneously in Circulation @CircAHA - here are some main insights of the study 🧵👇
This quoted post is unavailable.
Zbigniew Putowski retweeted
Wielki sukces @wszczeklik! Prestiżowa konferencja, wyjątkowa sesja i największe polskie badanie! Gratulacje!
Olbrzymi sukces @wszczeklik i całego zespołu. Największe badanie w historii polskiej medycyny klinicznej zaprezentowane na kongresie @escardio w sesji Hot Line i opublikowane w @CircAHA. Brawa dla całego zespołu badawczego! Dobrze zrealizowany grant @AgencjaBadanMed.
Zbigniew Putowski retweeted
ANDROMEDA-PEGASUS on fire! Less than 2 months since the study started and steady increase in recruitment every day! @AndromedaShock @ThinkingCC @ESICM @FernandoRamasco @DrMiguelIbarra1 @ross_prager @ZPutowski
Zbigniew Putowski retweeted
We were the first to highlight that choosing a high target increases the risk of adverse events.
journals.lww.com/ccmjournal/…
Now, another piece of evidence—interrupted at interim analysis due to harm in the high-target group.
Are we ready for the era of Protective Hemodynamics?
journals.lww.com/co-critical…
Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial
CCR Journal Watch - tracking the critical care literature daily
criticalcarereviews.com/late…
Zbigniew Putowski retweeted
Less is more wins again. RCT of high MAP target in older adults w/sepsis, stopped early for harm, 39% mortality MAP 80-85 vs. 29% mortality MAP 65-70 link.springer.com/article/10…. Recall also that the 65 Trial hinted that MAP60 may be better than 65. How low can we go?






































